PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2020.5062021532367-377Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in GliomaLin Lin, Jinquan Cai, Zixiao Tan, Xiangqi Meng, Ruiyan Li, Yang Li, Chuanlu Jianghttp://e-crt.org/upload/pdf/crt-2020-506.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2020.506, http://e-crt.org/upload/pdf/crt-2020-506.pdf
Human Cell10.1007/s13577-018-0221-2201832141-50LRRC8A potentiates temozolomide sensitivity in glioma cells via activating mitochondria-dependent apoptotic pathwayChao Yang, Longshuang He, Gaofei Chen, Zeqian Ning, Zhibai Xiahttp://link.springer.com/article/10.1007/s13577-018-0221-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s13577-018-0221-2.pdf, http://link.springer.com/content/pdf/10.1007/s13577-018-0221-2.pdf
Pathobiology10.1159/000447951201684299-107Multicentric Glioma Develops via a Mutant IDH1-Independent Pathway: Immunohistochemical Study of Multicentric GliomaVega Karlowee, Vishwa Jeet Amatya, Hirofumi Hirano, Takeshi Takayasu, Ryo Nosaka, Manish Kolakshyapati, Masako Yoshihiro, Yukio Takeshima, Kazuhiko Sugiyama, Kazunori Arita, Kaoru Kurisu, Fumiyuki Yamasakihttps://www.karger.com/Article/Pdf/447951, https://www.karger.com/Article/Pdf/447951
Neuro-Oncology10.1093/neuonc/noy148.423201820suppl_6vi101-vi101EXTH-76. 1H AND HYPERPOLARIZED 13C MRS BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO TEMOZOLOMIDE THERAPYElavarasan Subramani, Chloe Najac, Georgios Batsios, Pavithra Viswanath, Marina Radoul, Anne Marie Gillespie, Russell Pieper, Sabrina Ronenhttp://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi101/26279966/noy148.423.pdf
Cancer10.1002/cncr.287322014120162440-2447Mutant IDH1 inhibits PI3K/Akt signaling in human gliomaPeter Birner, Stefan Pusch, Christo Christov, Stiliana Mihaylova, Kalina Toumangelova-Uzeir, Sevdalin Natchev, Sebastian F. Schoppmann, Andrey Tchorbanov, Berthold Streubel, Jochen Tuettenberg, Marin Guentchevhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.28732, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28732/fullpdf
10.21203/rs.2.11554/v12019Nuclear Factor I A Promotes Temozolomide Resistance in Glioblastoma via Transcriptional Regulation of Nuclear Factor κB PathwayXiao Yu, Maode Wang, Jie Zuo, Alafate Wahafu, Ruichun Li, Wei Wu, Chao Liu, Wanfu Xie, Jia Wanghttps://www.researchsquare.com/article/rs-2411/v1, https://www.researchsquare.com/article/rs-2411/v1.html
10.21203/rs.3.rs-304467/v12021ATM Knockdown renders Glioma resistant to Temozolomide by Inhibiting IFIT1 ExpressionLijuan Yang, Jinfeng Zhang, Shengmei Weng, Zhixiong Linhttps://www.researchsquare.com/article/rs-304467/v1, https://www.researchsquare.com/article/rs-304467/v1.html
Cell Death & Disease10.1038/s41419-017-0251-9201892Fasudil increases temozolomide sensitivity and suppresses temozolomide-resistant glioma growth via inhibiting ROCK2/ABCG2Xin Zhang, Xiuting Liu, Wei Zhou, Mengdi Yang, Yang Ding, Qing Wang, Rong Huhttp://www.nature.com/articles/s41419-017-0251-9, http://www.nature.com/articles/s41419-017-0251-9.pdf, http://www.nature.com/articles/s41419-017-0251-9.pdf
Tumor Biology10.1177/10104283176943072017393101042831769430Feedback regulation of methyl methanesulfonate and ultraviolet-sensitive gene clone 81 via ATM/Chk2 pathway contributes to the resistance of MCF-7 breast cancer cells to cisplatinJuan Lv, Ying Qian, Xiaoyan Ni, Xiuping Xu, Xuejun Donghttp://journals.sagepub.com/doi/pdf/10.1177/1010428317694307, http://journals.sagepub.com/doi/full-xml/10.1177/1010428317694307, http://journals.sagepub.com/doi/pdf/10.1177/1010428317694307
Neuro-Oncology10.1093/neuonc/noz175.354201921Supplement_6vi86-vi86EXTH-20. HYPERPOLARIZED [2-13C] PYRUVATE TO [5-13C] GLUTAMATE AS BIOMARKERS OF IDH1 MUTANT GLIOMA RESPONSE TO TEMOZOLOMIDE THERAPYElavarasan Subramani, Chloe Najac, Georgios Batsios, Pavithra Viswanath, Marina Radoul, Anne Marie Gillespie, Russell O Pieper, Sabrina Ronenhttp://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_6/vi86/30633807/noz175.354.pdf, http://academic.oup.com/neuro-oncology/article-pdf/21/Supplement_6/vi86/30633807/noz175.354.pdf